TELLAPRIALBI
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
The APRI and ALBI scores are commonly used in clinical routine to assess the severity of illness for patients suffering from hepatical tumors and to predict postoperative liver dysfunction after resection. Combining these scores, the APRI+ALBI score provides even better performance of assessment and prediction regarding 30-day-mortality after surgery.
TELLAPRIALBI allows you to
- enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels)
- automatically compute APRI, ALBI and APRI+ALBI scores for comparative review
- select from a variety of tumor types together with the respective extent of resection and
- view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score.
The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app.
TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.
Hide..
Show more..
TELLAPRIALBI allows you to
- enter relevant lab parameters (platelet count, AST, albumin and bilirubin levels)
- automatically compute APRI, ALBI and APRI+ALBI scores for comparative review
- select from a variety of tumor types together with the respective extent of resection and
- view clinical interpretation plots regarding 30-day-mortality post operation highlighting the risk class indicated by the APRI+ALBI score.
The app is intended for educational use by medical professionals and to allow review of the APRI+ALBI score and its predictive quality. All information entered into the app and computed by it is processed exclusively within the app on the users device and no information is stored, transmitted or shared by the app.
TELLAPRIALBI was developed jointly by the Translational Experimental Liver Laboratory at the Medical University of Vienna (TELLVIENNA) and Howto Health GmbH. It is based on a joint research paper which is currently in print at BMJ Open. The app is published by and the service is provided by Howto Health GmbH.
Screenshots
User Rating
0 out of 5
0 ratings in Ecuador
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
mEMA-10: Legacy
|
0
|
1 year ago | |
HIV Clinical Job Aids
|
0
|
6 months ago | |
FRS Risk
fistula calculation
|
0
|
2 years ago | |
Accu TCM Habit App
Traditional Chinese Medicine
|
0
|
1 year ago | |
Inside Vascular Interventions
|
0
|
1 year ago | |
Pancreatic Surgery
N/A/
|
0
|
1 year ago | |
Hepatox
|
0
|
1 year ago | |
Sleep Apnea Screener 2
Sleep Apnea screens on mobile.
|
0
|
1 year ago | |
EVIglance
Evidence at a glance
|
0
|
1 month ago | |
Liver+AI
|
0
|
7 months ago |
Show More
Revenue and Downloads
Gain valuable insights into TELLAPRIALBI performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- Howto Health GmbH
- Languages
- English
- Recent version
- 1.3.2 (2 years ago )
- Released on
- Jan 7, 2021 (3 years ago )
- Also available in
- Germany, Poland, Italy, Japan, South Korea, Kazakhstan, Mexico, Norway, New Zealand, Peru, Pakistan, India, Portugal, Singapore, Thailand, Turkey, Taiwan, United States, Vietnam, South Africa, Algeria, Australia, Brazil, Belarus, Canada, Switzerland, Chile, Colombia, Dominican Republic, Argentina, Ecuador, Egypt, Spain, France, United Kingdom, Greece, Hong Kong, Israel
- Last updated
- 4 weeks ago